Literature DB >> 31131803

Screening and managing a low-risk pregnant population using continuous-wave Doppler ultrasound in a low-income population: A cohort analytical study.

S Nkosi1, J Makin, T Hlongwane, R C Pattinson.   

Abstract

BACKGROUND: In South Africa (SA), the largest category of perinatal deaths is unexplained stillbirths. Two-thirds of these occur in the antenatal period and most fetuses are macerated, but at antenatal clinics the mothers were generally regarded as healthy, with low-risk pregnancies. Innovative methods are urgently required to detect fetuses at risk of stillbirth and manage the mothers appropriately.
OBJECTIVES: To determine the prevalence of raised resistance indices (RIs) of the umbilical artery in a low-risk, low-income population and ascertain whether use of this information can prevent perinatal deaths.
METHODS: A descriptive study was performed in Mamelodi township, east of Pretoria, SA, on pregnant women attending antenatal clinics draining to two community health centres (CHCs). These women, classified as having low-risk pregnancies, were screened for placental insufficiency using a continuous-wave Doppler ultrasound apparatus (Umbiflow) between 28 and 32 weeks' gestation. When a raised RI was detected, the mother was referred to a high-risk clinic and managed according to a standard protocol. A cohort analytical study compared women who attended antenatal care at the same clinics as the Umbiflow group but did not have an Umbiflow test with those who had an Umbiflow test. The outcomes of all the deliveries in Mamelodi were recorded. The prevalences of abnormal RIs, absent end-diastolic flow (AEDF), stillbirths and neonatal deaths were the main outcome measures.
RESULTS: An Umbiflow RI was performed in 2 868 women, and pregnancy outcome was available for 2 539 fetuses (88.5%); 297 fetuses (11.7%) were regarded as at high risk. AEDF was found in 1.5% of the population screened with an outcome. There were 29 perinatal deaths in the Umbiflow group (low risk n=18, high risk n=11). The perinatal mortality rate for 12 168 women attending the CHCs and the antenatal clinics draining to the CHCs who did not have an RI was 21.3/1 000 births, significantly higher than that in the Umbiflow group (11.4/1 000 births) (risk ratio 0.58, 95% confidence interval 0.42 - 0.81).
CONCLUSIONS: The prevalence of AEDF in this low-risk population is ~10 times higher than that previously recorded. Use of the information prevented a number of perinatal deaths, most of which would have been macerated stillbirths. Screening a low-risk pregnant population using continuous-wave Doppler ultrasound may substantially reduce the prevalence of unexplained stillbirths in SA.

Entities:  

Mesh:

Year:  2019        PMID: 31131803     DOI: 10.7196/SAMJ.2019.v109i5.13611

Source DB:  PubMed          Journal:  S Afr Med J


  9 in total

1.  Strong Association Between Placental Pathology and Second-trimester Miscarriage.

Authors:  H J Odendaal
Journal:  Arch Obstet Gynaecol       Date:  2021

2.  The prevalence of abnormal Doppler's of the umbilical artery in a low-risk pregnant population in South Africa.

Authors:  Tmag Hlongwane; T Cronje; Bss Nkosi; R C Pattinson
Journal:  EClinicalMedicine       Date:  2021-03-18

3.  Prevalence of abnormal umbilical arterial flow on Doppler ultrasound in low-risk and unselected pregnant women: a systematic review.

Authors:  Joshua P Vogel; Valerie Vannevel; Gianna Robbers; George Gwako; Tina Lavin; Abiodun Adanikin; Tsakane Hlongwane; Robert C Pattinson; Zahida P Qureshi; Olufemi T Oladapo
Journal:  Reprod Health       Date:  2021-02-12       Impact factor: 3.223

4.  Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment.

Authors:  Lucia Hug; Danzhen You; Hannah Blencowe; Anu Mishra; Zhengfan Wang; Miranda J Fix; Jon Wakefield; Allisyn C Moran; Victor Gaigbe-Togbe; Emi Suzuki; Dianna M Blau; Simon Cousens; Andreea Creanga; Trevor Croft; Kenneth Hill; K S Joseph; Salome Maswime; Elizabeth M McClure; Robert Pattinson; Jon Pedersen; Lucy K Smith; Jennifer Zeitlin; Leontine Alkema
Journal:  Lancet       Date:  2021-08-28       Impact factor: 79.321

5.  Antenatal Doppler screening for fetuses at risk of adverse outcomes: a multicountry cohort study of the prevalence of abnormal resistance index in low-risk pregnant women.

Authors:  Valerie Vannevel; Joshua P Vogel; Robert C Pattinson; Richard Adanu; Umesh Charantimath; Shivaprasad S Goudar; George Gwako; Avinash Kavi; Ernest Maya; Alfred Osoti; Yeshita Pujar; Zahida P Qureshi; Stephen Rulisa; Tanita Botha; Olufemi T Oladapo
Journal:  BMJ Open       Date:  2022-03-16       Impact factor: 2.692

6.  Perinatal Mortality and its Causes in a Rural Block in Tamil Nadu, Southern India: A Community-Based Nonconcurrent Cohort Study.

Authors:  Anne George Cherian; Cherryl Tryphena; Kuryan George; Vinod Joseph Abraham; Venkata Raghava Mohan; Jasmine Helan Prasad
Journal:  Indian J Community Med       Date:  2022-03-16

7.  Preventing antenatal stillbirths: An innovative approach for primary health care.

Authors:  Tsakane M Hlongwane; Tanita Botha; Bongani S Nkosi; Robert C Pattinson
Journal:  S Afr Fam Pract (2004)       Date:  2022-08-25

8.  Where is the 'C' in antenatal care and postnatal care: A multi-country survey of availability of antenatal and postnatal care in low- and middle-income settings.

Authors:  Barbara Madaj; Somasundari Gopalakrishnan; Alexandre Quach; Simone Filiaci; Adama Traore; Dankom Bakusa; Mselenge Mdegela; Abdul Wali Yousofzai; Ahmed Javed Rahmanzai; Grace Kodindo; Jean-Pierre Gami; Njiki Dounou Rostand; Hamit Kessely; Stephen Ayisi Addo; Mercy Abbey; Mary Sapali; Ali Omar; Alex Ernest; Rugola Mtandu; Abram Agossou; Guillaume K Ketoh; Nicholas Furtado; Viviana Mangiaterra; Nynke van den Broek
Journal:  BJOG       Date:  2022-02-17       Impact factor: 7.331

9.  The ability of continuous-wave Doppler ultrasound to detect fetal growth restriction.

Authors:  Ute Feucht; Helen Mulol; Valerie Vannevel; Robert Pattinson
Journal:  PLoS One       Date:  2021-08-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.